Tema Oncology ETF (NASDAQ:CANC) Short Interest Update

Tema Oncology ETF (NASDAQ:CANC) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 2,200 shares, a growth of 175.0% from the November 15th total of 800 shares. Based on an average daily volume of 2,800 shares, the days-to-cover ratio is presently 0.8 days.

Tema Oncology ETF Stock Performance

Shares of CANC stock traded down $0.51 during trading on Friday, hitting $25.04. 4,460 shares of the company were exchanged, compared to its average volume of 6,521. The firm has a market capitalization of $43.57 million, a price-to-earnings ratio of 26.86 and a beta of 1.11. The business’s 50-day simple moving average is $27.66 and its 200 day simple moving average is $28.09. Tema Oncology ETF has a twelve month low of $24.94 and a twelve month high of $30.11.

Tema Oncology ETF Announces Dividend

The business also recently declared a dividend, which was paid on Thursday, December 12th. Stockholders of record on Wednesday, December 11th were issued a dividend of $0.7283 per share. The ex-dividend date of this dividend was Wednesday, December 11th.

Hedge Funds Weigh In On Tema Oncology ETF

A hedge fund recently bought a new stake in Tema Oncology ETF stock. Thrivent Financial for Lutherans bought a new stake in Tema Oncology ETF (NASDAQ:CANC) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 319,376 shares of the company’s stock, valued at approximately $8,616,000. Thrivent Financial for Lutherans owned approximately 19.01% of Tema Oncology ETF at the end of the most recent reporting period.

About Tema Oncology ETF

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.